Caris Life Sciences: Dave Fredrickson

Caris Life Sciences has appointed David Fredrickson to its board of directors. Fredrickson is executive VP of the oncology business unit at AstraZeneca, a position he has held since October of 2017. He was previously president of AstraZeneca Japan, and VP, specialty care of AstraZeneca US. He also previously served as vice chairman of the European Federation of Pharmaceutical Industries and Associations in Japan and director of the Japan Pharmaceutical Manufacturers Association. Prior to AstraZeneca, he held leadership positions at Roche/Genentech, including oncology business unit manager in Spain and strategy, marketing, and sales roles in the US. He has also worked at the Monitor Group (now Monitor Deloitte Group), a global strategy consultancy. Fredrickson earned a BA degree in government from Georgetown University.